A citation-based method for searching scientific literature

Eleftherios P Mamounas, Ann Brown, Stewart Anderson, Roy Smith, Thomas Julian, Barbara Miller, Harry D Bear, Christopher B Caldwell, Alonzo P Walker, Wendy M Mikkelson, Jay S Stauffer, Andre Robidoux, Heather Theoret, Atilla Soran, Bernard Fisher, D Lawrence Wickerham, Norman Wolmark. J Clin Oncol 2005
Times Cited: 323







List of co-cited articles
481 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study.
Thorsten Kuehn, Ingo Bauerfeind, Tanja Fehm, Barbara Fleige, Maik Hausschild, Gisela Helms, Annette Lebeau, Cornelia Liedtke, Gunter von Minckwitz, Valentina Nekljudova,[...]. Lancet Oncol 2013
601
80

Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial.
Judy C Boughey, Vera J Suman, Elizabeth A Mittendorf, Gretchen M Ahrendt, Lee G Wilke, Bret Taback, A Marilyn Leitch, Henry M Kuerer, Monet Bowling, Teresa S Flippo-Morton,[...]. JAMA 2013
655
75

Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study.
Jean-Francois Boileau, Brigitte Poirier, Mark Basik, Claire M B Holloway, Louis Gaboury, Lucas Sideris, Sarkis Meterissian, Angel Arnaout, Muriel Brackstone, David R McCready,[...]. J Clin Oncol 2015
329
66

Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection.
Abigail S Caudle, Wei T Yang, Savitri Krishnamurthy, Elizabeth A Mittendorf, Dalliah M Black, Michael Z Gilcrease, Isabelle Bedrosian, Brian P Hobbs, Sarah M DeSnyder, Rosa F Hwang,[...]. J Clin Oncol 2016
329
45

Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial.
David N Krag, Stewart J Anderson, Thomas B Julian, Ann M Brown, Seth P Harlow, Joseph P Costantino, Takamaru Ashikaga, Donald L Weaver, Eleftherios P Mamounas, Lynne M Jalovec,[...]. Lancet Oncol 2010
917
38

Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer.
Y Xing, M Foy, D D Cox, H M Kuerer, K K Hunt, J N Cormier. Br J Surg 2006
243
36

Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial.
Armando E Giuliano, Kelly K Hunt, Karla V Ballman, Peter D Beitsch, Pat W Whitworth, Peter W Blumencranz, A Marilyn Leitch, Sukamal Saha, Linda M McCall, Monica Morrow. JAMA 2011
30

Sentinel lymph node biopsy after neoadjuvant chemotherapy for advanced breast cancer: results of Ganglion Sentinelle et Chimiotherapie Neoadjuvante, a French prospective multicentric study.
Jean-Marc Classe, Virginie Bordes, Loic Campion, Herve Mignotte, François Dravet, Jean Leveque, Christine Sagan, Pierre François Dupre, Gilles Body, Sylvia Giard. J Clin Oncol 2009
144
30

Identification and Resection of Clipped Node Decreases the False-negative Rate of Sentinel Lymph Node Surgery in Patients Presenting With Node-positive Breast Cancer (T0-T4, N1-N2) Who Receive Neoadjuvant Chemotherapy: Results From ACOSOG Z1071 (Alliance).
Judy C Boughey, Karla V Ballman, Huong T Le-Petross, Linda M McCall, Elizabeth A Mittendorf, Gretchen M Ahrendt, Lee G Wilke, Bret Taback, Eric C Feliberti, Kelly K Hunt. Ann Surg 2016
202
30

Sentinel lymph node surgery after neoadjuvant chemotherapy is accurate and reduces the need for axillary dissection in breast cancer patients.
Kelly K Hunt, Min Yi, Elizabeth A Mittendorf, Cynthia Guerrero, Gildy V Babiera, Isabelle Bedrosian, Rosa F Hwang, Henry M Kuerer, Merrick I Ross, Funda Meric-Bernstam. Ann Surg 2009
172
28

Accuracy of sentinel node biopsy after neoadjuvant chemotherapy in breast cancer patients: a systematic review.
Carolien H M van Deurzen, Birgit E P J Vriens, Vivianne C G Tjan-Heijnen, Elsken van der Wall, Mirjam Albregts, Richard van Hilligersberg, Evelyn M Monninkhof, Paul J van Diest. Eur J Cancer 2009
119
28

The role for sentinel lymph node dissection after neoadjuvant chemotherapy in patients who present with node-positive breast cancer.
Rosalinda Alvarado, Min Yi, Huong Le-Petross, Michael Gilcrease, Elizabeth A Mittendorf, Isabelle Bedrosian, Rosa F Hwang, Abigail S Caudle, Gildy V Babiera, Jeri S Akins,[...]. Ann Surg Oncol 2012
112
27

Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18.
B Fisher, A Brown, E Mamounas, S Wieand, A Robidoux, R G Margolese, A B Cruz, E R Fisher, D L Wickerham, N Wolmark,[...]. J Clin Oncol 1997
27

Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial.
Viviana Galimberti, Bernard F Cole, Stefano Zurrida, Giuseppe Viale, Alberto Luini, Paolo Veronesi, Paola Baratella, Camelia Chifu, Manuela Sargenti, Mattia Intra,[...]. Lancet Oncol 2013
665
25

Marking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients: the MARI procedure.
Mila Donker, Marieke E Straver, Jelle Wesseling, Claudette E Loo, Margaret Schot, Caroline A Drukker, Harm van Tinteren, Gabe S Sonke, Emiel J Th Rutgers, Marie-Jeanne T F D Vrancken Peeters. Ann Surg 2015
185
25

Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph-node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial.
David N Krag, Stewart J Anderson, Thomas B Julian, Ann M Brown, Seth P Harlow, Takamaru Ashikaga, Donald L Weaver, Barbara J Miller, Lynne M Jalovec, Thomas G Frazier,[...]. Lancet Oncol 2007
639
23


Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial.
Mila Donker, Geertjan van Tienhoven, Marieke E Straver, Philip Meijnen, Cornelis J H van de Velde, Robert E Mansel, Luigi Cataliotti, A Helen Westenberg, Jean H G Klinkenbijl, Lorenzo Orzalesi,[...]. Lancet Oncol 2014
762
22

Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial.
Robert E Mansel, Lesley Fallowfield, Mark Kissin, Amit Goyal, Robert G Newcombe, J Michael Dixon, Constantinos Yiangou, Kieran Horgan, Nigel Bundred, Ian Monypenny,[...]. J Natl Cancer Inst 2006
21

Sentinel lymph node biopsy performed after neoadjuvant chemotherapy is accurate in patients with documented node-positive breast cancer at presentation.
Erika A Newman, Michael S Sabel, Alexis V Nees, Anne Schott, Kathleen M Diehl, Vincent M Cimmino, Alfred E Chang, Celina Kleer, Daniel F Hayes, Lisa A Newman. Ann Surg Oncol 2007
103
20

Sentinel node biopsy after neoadjuvant treatment in breast cancer: Five-year follow-up of patients with clinically node-negative or node-positive disease before treatment.
V Galimberti, S K Ribeiro Fontana, P Maisonneuve, F Steccanella, A R Vento, M Intra, P Naninato, P Caldarella, M Iorfida, M Colleoni,[...]. Eur J Surg Oncol 2016
77
25

Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases.
Jeannie Shen, Michael Z Gilcrease, Gildy V Babiera, Merrick I Ross, Funda Meric-Bernstam, Barry W Feig, Henry M Kuerer, Ashleigh Francis, Frederick C Ames, Kelly K Hunt. Cancer 2007
109
20


Outcome after pathologic complete eradication of cytologically proven breast cancer axillary node metastases following primary chemotherapy.
Bryan T Hennessy, Gabriel N Hortobagyi, Roman Rouzier, Henry Kuerer, Nour Sneige, Aman U Buzdar, Shu Wan Kau, Bruno Fornage, Aysegul Sahin, Kristine Broglio,[...]. J Clin Oncol 2005
272
18

Factors affecting sentinel lymph node identification rate after neoadjuvant chemotherapy for breast cancer patients enrolled in ACOSOG Z1071 (Alliance).
Judy C Boughey, Vera J Suman, Elizabeth A Mittendorf, Gretchen M Ahrendt, Lee G Wilke, Bret Taback, A Marilyn Leitch, Teresa S Flippo-Morton, Henry M Kuerer, Monet Bowling,[...]. Ann Surg 2015
82
21

Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update.
Gary H Lyman, Sarah Temin, Stephen B Edge, Lisa A Newman, Roderick R Turner, Donald L Weaver, Al B Benson, Linda D Bosserman, Harold J Burstein, Hiram Cody,[...]. J Clin Oncol 2014
458
18

A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer.
Umberto Veronesi, Giovanni Paganelli, Giuseppe Viale, Alberto Luini, Stefano Zurrida, Viviana Galimberti, Mattia Intra, Paolo Veronesi, Chris Robertson, Patrick Maisonneuve,[...]. N Engl J Med 2003
18

Incidence and impact of documented eradication of breast cancer axillary lymph node metastases before surgery in patients treated with neoadjuvant chemotherapy.
H M Kuerer, A A Sahin, K K Hunt, L A Newman, T M Breslin, F C Ames, M I Ross, A U Buzdar, G N Hortobagyi, S E Singletary. Ann Surg 1999
253
18

Axillary Ultrasound After Neoadjuvant Chemotherapy and Its Impact on Sentinel Lymph Node Surgery: Results From the American College of Surgeons Oncology Group Z1071 Trial (Alliance).
Judy C Boughey, Karla V Ballman, Kelly K Hunt, Linda M McCall, Elizabeth A Mittendorf, Gretchen M Ahrendt, Lee G Wilke, Huong T Le-Petross. J Clin Oncol 2015
121
17

Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis.
Patricia Cortazar, Lijun Zhang, Michael Untch, Keyur Mehta, Joseph P Costantino, Norman Wolmark, Hervé Bonnefoi, David Cameron, Luca Gianni, Pinuccia Valagussa,[...]. Lancet 2014
16

Cytologically proven axillary lymph node metastases are eradicated in patients receiving preoperative chemotherapy with concurrent trastuzumab for HER2-positive breast cancer.
Laura S Dominici, Viviana M Negron Gonzalez, Aman U Buzdar, Anthony Lucci, Elizabeth A Mittendorf, Huong T Le-Petross, Gildy V Babiera, Funda Meric-Bernstam, Kelly K Hunt, Henry M Kuerer. Cancer 2010
131
15

Lymphatic mapping and sentinel lymphadenectomy for breast cancer.
A E Giuliano, D M Kirgan, J M Guenther, D L Morton. Ann Surg 1994
15

Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27.
Priya Rastogi, Stewart J Anderson, Harry D Bear, Charles E Geyer, Morton S Kahlenberg, André Robidoux, Richard G Margolese, James L Hoehn, Victor G Vogel, Shaker R Dakhil,[...]. J Clin Oncol 2008
14

Predictors of locoregional recurrence after neoadjuvant chemotherapy: results from combined analysis of National Surgical Adjuvant Breast and Bowel Project B-18 and B-27.
Eleftherios P Mamounas, Stewart J Anderson, James J Dignam, Harry D Bear, Thomas B Julian, Charles E Geyer, Alphonse Taghian, D Lawrence Wickerham, Norman Wolmark. J Clin Oncol 2012
301
14

Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study.
Jean-Marc Classe, Cecile Loaec, P Gimbergues, S Alran, C Tunon de Lara, P F Dupre, Roman Rouzier, C Faure, N Paillocher, M P Chauvet,[...]. Breast Cancer Res Treat 2019
52
26

Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Patients With an Initial Diagnosis of Cytology-Proven Lymph Node-Positive Breast Cancer.
Katsutoshi Enokido, Chie Watanabe, Seigo Nakamura, Akiko Ogiya, Tomo Osako, Futoshi Akiyama, Akiyo Yoshimura, Hiroji Iwata, Shinji Ohno, Yasuyuki Kojima,[...]. Clin Breast Cancer 2016
32
40

Tumor biology correlates with rates of breast-conserving surgery and pathologic complete response after neoadjuvant chemotherapy for breast cancer: findings from the ACOSOG Z1071 (Alliance) Prospective Multicenter Clinical Trial.
Judy C Boughey, Linda M McCall, Karla V Ballman, Elizabeth A Mittendorf, Gretchen M Ahrendt, Lee G Wilke, Bret Taback, A Marilyn Leitch, Teresa Flippo-Morton, Kelly K Hunt. Ann Surg 2014
204
13

Initial results with preoperative tattooing of biopsied axillary lymph nodes and correlation to sentinel lymph nodes in breast cancer patients.
Nicole Choy, Jafi Lipson, Catherine Porter, Michael Ozawa, Anne Kieryn, Sunita Pal, Jennifer Kao, Long Trinh, Amanda Wheeler, Debra Ikeda,[...]. Ann Surg Oncol 2015
61
21

Sentinel node identification rate, but not accuracy, is significantly decreased after pre-operative chemotherapy in axillary node-positive breast cancer patients.
Seeyoun Lee, Eun Young Kim, Seok Hyung Kang, Seok Won Kim, Seok-Ki Kim, Keon Wook Kang, Youngmee Kwon, Kyung Hwan Shin, Han-Sung Kang, Jungsil Ro,[...]. Breast Cancer Res Treat 2007
63
19


Complete axillary lymph node dissection versus clinical follow-up in breast cancer patients with sentinel node micrometastasis: final results from the multicenter clinical trial AATRM 048/13/2000.
Montserrat Solá, José A Alberro, Manuel Fraile, Pilar Santesteban, Manuel Ramos, Rafael Fabregas, Antonio Moral, Blas Ballester, Sergi Vidal. Ann Surg Oncol 2013
146
12


Axillary Nodal Management Following Neoadjuvant Chemotherapy: A Review.
Melissa Pilewskie, Monica Morrow. JAMA Oncol 2017
85
14

Axillary Staging After Neoadjuvant Chemotherapy for Breast Cancer: A Pilot Study Combining Sentinel Lymph Node Biopsy with Radioactive Seed Localization of Pre-treatment Positive Axillary Lymph Nodes.
Emilia J Diego, Priscilla F McAuliffe, Atilla Soran, Kandace P McGuire, Ronald R Johnson, Marguerite Bonaventura, Gretchen M Ahrendt. Ann Surg Oncol 2016
75
16

Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial.
Armando E Giuliano, Karla V Ballman, Linda McCall, Peter D Beitsch, Meghan B Brennan, Pond R Kelemen, David W Ollila, Nora M Hansen, Pat W Whitworth, Peter W Blumencranz,[...]. JAMA 2017
481
12

Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.
B Fisher, J Bryant, N Wolmark, E Mamounas, A Brown, E R Fisher, D L Wickerham, M Begovic, A DeCillis, A Robidoux,[...]. J Clin Oncol 1998
11


How Often Does Neoadjuvant Chemotherapy Avoid Axillary Dissection in Patients With Histologically Confirmed Nodal Metastases? Results of a Prospective Study.
Anita Mamtani, Andrea V Barrio, Tari A King, Kimberly J Van Zee, George Plitas, Melissa Pilewskie, Mahmoud El-Tamer, Mary L Gemignani, Alexandra S Heerdt, Lisa M Sclafani,[...]. Ann Surg Oncol 2016
141
11

Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial.
Luca Gianni, Tadeusz Pienkowski, Young-Hyuck Im, Laslo Roman, Ling-Ming Tseng, Mei-Ching Liu, Ana Lluch, Elżbieta Staroslawska, Juan de la Haba-Rodriguez, Seock-Ah Im,[...]. Lancet Oncol 2012
11

Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial.
Armando E Giuliano, Linda McCall, Peter Beitsch, Pat W Whitworth, Peter Blumencranz, A Marilyn Leitch, Sukamal Saha, Kelly K Hunt, Monica Morrow, Karla Ballman. Ann Surg 2010
770
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.